Literature DB >> 24336154

Lack of presence of the human cytomegalovirus in human glioblastoma.

Yoriko Yamashita1, Yoshinori Ito2, Hiroki Isomura3, Naoaki Takemura4, Akira Okamoto5, Kazuya Motomura6, Takashi Tsujiuchi6, Atsushi Natsume6, Toshihiko Wakabayashi6, Shinya Toyokuni4, Tatsuya Tsurumi7.   

Abstract

Recent reports have indicated human cytomegalovirus (HCMV) to be associated with human glioblastoma carcinogenesis. In established examples of viral carcinogenesis, viral DNA and one or more of its products have been detected in most tumor cells of biopsies in the majority of cases. To test whether HCMV is associated with human glioblastoma based on this criterion, we measured the number of viral DNA molecules per cell in both frozen and paraffin-embedded tumor biopsies from 58 patients using real-time quantitative PCR (QPCR). Immunohistochemical and fluorescence in situ hybridization (FISH) to detect HCMV proteins and genome was performed in 10 cases using formalin-fixed paraffin-embedded glioblastoma tissues. Southern blotting using DNA extracted from four glioblastoma cell lines together with immunoblotting using the four cell lines and five glioblastoma tissue samples were also performed. We further confirmed the immunoblot bands using liquid chromatography-tandem mass spectrometry assay. As a result, HCMV DNA was not detected in the tumor cells from any of the glioblastoma cases by QPCR detecting two different HCMV genes, in clear contrast to samples from patients with HCMV infection. Southern blotting and immunoblotting of cell lines and FISH using paraffin sections were all negative. However, immunoblotting and immunohistochemistry using tissue samples were partly positive, but HCMV proteins were not detected by proteomic analysis, suggesting false positivity of the analyses. As our QPCR analysis could detect 10 copies of HCMV DNA mixed with DNA extracted from 10(4) HCMV-negative cells, we conclude that HCMV is not persistent, at least in the tumor cells, of developed human glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24336154     DOI: 10.1038/modpathol.2013.219

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  24 in total

1.  Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples.

Authors:  Marie-Pierre Loit; Homa Adle-Biassette; Schahrazed Bouazza; Marie-Christine Mazeron; Philippe Manivet; Jacqueline Lehmann-Che; Natacha Teissier; Emmanuel Mandonnet; Jean-Michel Molina
Journal:  J Neurovirol       Date:  2018-11-05       Impact factor: 2.643

2.  Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.

Authors:  Peter Baumgarten; Martin Michaelis; Florian Rothweiler; Tatjana Starzetz; Holger F Rabenau; Annemarie Berger; Lukas Jennewein; Anne K Braczynski; Kea Franz; Volker Seifert; Joachim P Steinbach; Regina Allwinn; Michel Mittelbronn; Jindrich Cinatl
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

3.  Absence of human cytomegalovirus infection in childhood brain tumors.

Authors:  Iacopo Sardi; Maurizio Lucchesi; Sabrina Becciani; Ludovica Facchini; Milena Guidi; Anna Maria Buccoliero; Maria Moriondo; Gianna Baroni; Alessia Stival; Silvia Farina; Lorenzo Genitori; Maurizio de Martino
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

4.  Cancer cell stemness, responses to experimental genotoxic treatments, cytomegalovirus protein expression and DNA replication stress in pediatric medulloblastomas.

Authors:  Jiri Bartek; Joanna M Merchut-Maya; Apolinar Maya-Mendoza; Olesja Fornara; Afsar Rahbar; Christian Beltoft Bröchner; Astrid Sehested; Cecilia Söderberg-Nauclér; Jiri Bartek; Jirina Bartkova
Journal:  Cell Cycle       Date:  2020-02-13       Impact factor: 4.534

Review 5.  Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options.

Authors:  Cecilia Söderberg-Nauclér; John Inge Johnsen
Journal:  World J Exp Med       Date:  2015-02-20

6.  Prevalence of Neurotropic Viruses in Malignant Glioma and Their Onco-Modulatory Potential.

Authors:  Tadej Strojnik; Darja Duh; Tamara T Lah
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

7.  Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization.

Authors:  Matthias Holdhoff; Gunes Guner; Fausto J Rodriguez; Jessica L Hicks; Qizhi Zheng; Michael S Forman; Xiaobu Ye; Stuart A Grossman; Alan K Meeker; Christopher M Heaphy; Charles G Eberhart; Angelo M De Marzo; Ravit Arav-Boger
Journal:  Clin Cancer Res       Date:  2016-12-29       Impact factor: 12.531

Review 8.  The Association of Human Herpesviruses with Malignant Brain Tumor Pathology and Therapy: Two Sides of a Coin.

Authors:  Evita Athanasiou; Antonios N Gargalionis; Fotini Boufidou; Athanassios Tsakris
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

Review 9.  The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme.

Authors:  Amin Daei Sorkhabi; Aila Sarkesh; Hossein Saeedi; Faroogh Marofi; Mahnaz Ghaebi; Nicola Silvestris; Behzad Baradaran; Oronzo Brunetti
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

10.  Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects.

Authors:  Yumiko Hashida; Ayuko Taniguchi; Toshio Yawata; Sena Hosokawa; Masanao Murakami; Makoto Hiroi; Tetsuya Ueba; Masanori Daibata
Journal:  Infect Agent Cancer       Date:  2015-01-27       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.